Q SYNTHESIS LLC
  • Quality Improvement
  • Systems Thinking
  • Implementation Science
  • Publications
  • About
  • Contact
  • Updates

HER2-low and HER2-ultralow breast cancer resources

5/2/2025

0 Comments

 
ASCP has recently developed several CME activities on the topic of HER2-low and HER2-ultralow breast cancer:

Best Practices in HER2-low and HER2-ultralow Advanced Breast Cancer: IHC Testing and Interpretation
Link: https://store.ascp.org/productlisting/productdetail?productId=176966209

Best Practices in HER2-low and HER2-ultralow Advanced Breast Cancer: Emerging Science and Current Treatment
Link: https://store.ascp.org/productlisting/productdetail?productId=176989985

Best Practices in HER2-low and HER2-ultralow Advanced Breast Cancer: Reproducibility of Testing
Link: https://store.ascp.org/productlisting/productdetail?productId=176990098
​

0 Comments

Your comment will be posted after it is approved.


Leave a Reply.

    Author

    @DrJosephKim
    Joseph Kim, MD, MPH, MBA, FACEHP is the Founder and President of Q Synthesis LLC.

    ​View Dr. Kim's bio on LinkedIn. 

    ​


    Sign up to receive updates:
Q Synthesis LLC
Home

About

Contact
​

​Publications
Picture
​Quality Improvement 
​
Systems Thinking 

​Implementation Science 

​Updates
www.qsynthesis.com
  • Quality Improvement
  • Systems Thinking
  • Implementation Science
  • Publications
  • About
  • Contact
  • Updates